Morteza Ghasemnejad-Berenji

InstitutionUrmia University of Medical Sciences
AddressUrmia
Iran
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 10 Covid-19 publications, with a maximum of 3 publications in October 2020 and April 2021
    All Publications
    Bar chart showing 11 publications over 3 distinct years, with a maximum of 6 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Khezri MR, Ghasemnejad-Berenji M. Neurological effects of elevated levels of angiotensin II in COVID-19 patients. Hum Cell. 2021 Nov; 34(6):1941-1942. PMID: 34449020.
      Citations: 1     Fields:    Translation:Humans
    2. Khezri MR, Zolbanin NM, Ghasemnejad-Berenji M, Jafari R. Azithromycin: Immunomodulatory and antiviral properties for SARS-CoV-2 infection. Eur J Pharmacol. 2021 Aug 15; 905:174191. PMID: 34015317.
      Citations: 2     Fields:    Translation:Humans
    3. Jafari A, Sadeghpour S, Ghasemnejad-Berenji H, Pashapour S, Ghasemnejad-Berenji M. Potential Antioxidative, Anti-inflammatory and Immunomodulatory Effects of Ghrelin, an Endogenous Peptide from the Stomach in SARS-CoV2 Infection. Int J Pept Res Ther. 2021; 27(3):1875-1883. PMID: 33880115.
      Citations: 2     
    4. Khezri MR, Yousefi K, Ghasemnejad-Berenji M. Angiotensin II: A possible target for therapeutic intervention in COVID-19. Biomed Pharmacother. 2021 07; 139:111564. PMID: 33848772.
      Citations: 1     Fields:    Translation:HumansAnimals
    5. Ghasemnejad-Berenji M. Immunomodulatory and anti-inflammatory potential of crocin in COVID-19 treatment. J Food Biochem. 2021 05; 45(5):e13718. PMID: 33817822.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    6. Ghasemnejad-Berenji M. mTOR inhibition: a double-edged sword in patients with COVID-19? Hum Cell. 2021 Mar; 34(2):698-699. PMID: 33527306.
      Citations: 2     Fields:    Translation:HumansCells
    7. Ghasemnejad-Berenji M, Pashapour S. Favipiravir and COVID-19: A Simplified Summary. Drug Res (Stuttg). 2021 Mar; 71(3):166-170. PMID: 33176367.
      Citations: 5     Fields:    Translation:Humans
    8. Ghasemnejad-Berenji M, Pashapour S, Ghasemnejad-Berenji H. Therapeutic potential for clomiphene, a selective estrogen receptor modulator, in the treatment of COVID-19. Med Hypotheses. 2020 12; 145:110354. PMID: 33129007.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    9. Ghasemnejad-Berenji M, Pashapour S, Sadeghpour S. Pentoxifylline: A Drug with Antiviral and Anti-Inflammatory Effects to Be Considered in the Treatment of Coronavirus Disease 2019. Med Princ Pract. 2021; 30(1):98-100. PMID: 33049737.
      Citations: 1     Fields:    Translation:Humans
    10. Ghasemnejad-Berenji M, Pashapour S. SARS-CoV-2 and the Possible Role of Raf/MEK/ERK Pathway in Viral Survival: Is This a Potential Therapeutic Strategy for COVID-19? Pharmacology. 2021; 106(1-2):119-122. PMID: 33011728.
      Citations: 8     Fields:    Translation:HumansAnimalsCells